Varghese Palath

Person

South San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of treating hematological proliferative disorders by target...
- Patent number 9,109,032
- Issue date Aug 18, 2015
- KaloBios Pharmaceuticals, Inc.
- Geoffrey T. Yarranton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-EMR1 antibodies
- Patent number 9,045,539
- Issue date Jun 2, 2015
- KaloBios Pharmaceuticals, Inc.
- Kenneth Luehrsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of leukemias and chronic myeloproliferative diseases with...
- Patent number 8,834,870
- Issue date Sep 16, 2014
- KaloBios Pharmaceuticals, Inc.
- Christopher R. Bebbington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating dementia using a GM-CSF antagonist
- Patent number 8,398,972
- Issue date Mar 19, 2013
- KaloBios Pharmaceuticals, Inc.
- Christopher R. Bebbington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Treatment of Leukemias and Chronic Myeloproliferative Diseases with...
- Publication number 20170226227
- Publication date Aug 10, 2017
- KaloBios Pharmaceuticals, Inc.
- Christopher R. Bebbington
- G01 - MEASURING TESTING
Information Patent Application
Methods of Treating Hematological Proliferative Disorders by Target...
- Publication number 20150329647
- Publication date Nov 19, 2015
- KaloBios Pharmaceuticals, Inc.
- Geoffrey T. Yarranton
- G01 - MEASURING TESTING
Information Patent Application
TREATMENT OF LEUKEMIAS AND CHRONIC MYELOPROLIFERATIVE DISEASES WITH...
- Publication number 20140370010
- Publication date Dec 18, 2014
- Christopher R. Bebbington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING DEMENTIA USING A GM-CSF ANTAGONIST
- Publication number 20130156759
- Publication date Jun 20, 2013
- KaloBios Pharmaceuticals, Inc.
- Christopher R. Bebbington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-EMR1 ANTIBODIES
- Publication number 20130064826
- Publication date Mar 14, 2013
- Kenneth Luehrsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING HEMATOLOGICAL PROLIFERATIVE DISORDERS BY TARGET...
- Publication number 20130039907
- Publication date Feb 14, 2013
- KaloBios Pharmaceuticals Inc.
- Geoffrey T. Yarranton
- G01 - MEASURING TESTING
Information Patent Application
DETECTION OF EPHA3 AS A MARKER OF THE PRESENCE OF A SOLID TUMOR
- Publication number 20110318304
- Publication date Dec 29, 2011
- Martin Lackmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EPHA3 ANTIBODIES FOR THE TREATMENT OF MULTIPLE MYELOMA
- Publication number 20110243934
- Publication date Oct 6, 2011
- KaloBios Pharmaceuticals Inc.
- Varghese Palath
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of Leukemias and Chronic Myeloproliferative Diseases with...
- Publication number 20100226930
- Publication date Sep 9, 2010
- KaloBios Pharmaceuticals, Inc.
- Christopher R. Bebbington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING DEMENTIA USING A GM-CSF ANTAGONIST
- Publication number 20100215650
- Publication date Aug 26, 2010
- KaloBios Pharmaceuticals, Inc.
- Christopher R. Bebbington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Varghese Palath

Person

Patents Grantslast 30 patents

Methods of treating hematological proliferative disorders by target...

Anti-EMR1 antibodies

Treatment of leukemias and chronic myeloproliferative diseases with...

Methods of treating dementia using a GM-CSF antagonist

Patents Applicationslast 30 patents

Treatment of Leukemias and Chronic Myeloproliferative Diseases with...

Methods of Treating Hematological Proliferative Disorders by Target...

TREATMENT OF LEUKEMIAS AND CHRONIC MYELOPROLIFERATIVE DISEASES WITH...

METHODS OF TREATING DEMENTIA USING A GM-CSF ANTAGONIST

ANTI-EMR1 ANTIBODIES

METHODS OF TREATING HEMATOLOGICAL PROLIFERATIVE DISORDERS BY TARGET...

DETECTION OF EPHA3 AS A MARKER OF THE PRESENCE OF A SOLID TUMOR

EPHA3 ANTIBODIES FOR THE TREATMENT OF MULTIPLE MYELOMA

Treatment of Leukemias and Chronic Myeloproliferative Diseases with...

METHODS OF TREATING DEMENTIA USING A GM-CSF ANTAGONIST